View in EDS

IGF2 supports glioblastoma growth and immune evasion through a combination of tumor cell-intrinsic and -extrinsic mechanisms.

Saved in:
Bibliographic Details
Title: IGF2 supports glioblastoma growth and immune evasion through a combination of tumor cell-intrinsic and -extrinsic mechanisms.
Authors: Heemskerk KM; Cumming School of Medicine, University of Calgary, Calgary, Alberta.; Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, Alberta., Assaf S; Cumming School of Medicine, University of Calgary, Calgary, Alberta.; Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, Alberta., Hao X; Cumming School of Medicine, University of Calgary, Calgary, Alberta.; Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, Alberta., Snelling S; Cumming School of Medicine, University of Calgary, Calgary, Alberta.; Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, Alberta., Meode M; Cumming School of Medicine, University of Calgary, Calgary, Alberta.; Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, Alberta., Hassam R; Cumming School of Medicine, University of Calgary, Calgary, Alberta.; Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, Alberta., Cseh O; Cumming School of Medicine, University of Calgary, Calgary, Alberta., Kala S; Standard BioTools, Canada Inc, Markham, Ontario., Pemberton J; Standard BioTools, Canada Inc, Markham, Ontario., Chan JA; Cumming School of Medicine, University of Calgary, Calgary, Alberta.; Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, Alberta., Cairncross JG; Cumming School of Medicine, University of Calgary, Calgary, Alberta.; Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, Alberta., Forsyth P; Mofitt Cancer Center and Research Institute, Tampa, Florida (P.F.)., Yong VW; Cumming School of Medicine, University of Calgary, Calgary, Alberta., Mirzaei R; Department of Oncology, University of Alberta, Edmonton, Alberta.; Cross Cancer Institute, University of Alberta, Edmonton, Alberta., Weiss S; Cumming School of Medicine, University of Calgary, Calgary, Alberta.; Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, Alberta., Zemp FJ; Cumming School of Medicine, University of Calgary, Calgary, Alberta.; Department of Biochemistry and Molecular Biology, University of Calgary, Calgary, Alberta., Luchman HA; Cumming School of Medicine, University of Calgary, Calgary, Alberta.; Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, Alberta.
Source: Neuro-oncology advances [Neurooncol Adv] 2025 Oct 15; Vol. 8 (1), pp. vdaf226. Date of Electronic Publication: 2025 Oct 15 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 101755003 Publication Model: eCollection Cited Medium: Internet ISSN: 2632-2498 (Electronic) Linking ISSN: 26322498 NLM ISO Abbreviation: Neurooncol Adv Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41568176
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: IGF2 supports glioblastoma growth and immune evasion through a combination of tumor cell-intrinsic and -extrinsic mechanisms.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Heemskerk+KM%22">Heemskerk KM</searchLink>; Cumming School of Medicine, University of Calgary, Calgary, Alberta.; Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, Alberta.<br /><searchLink fieldCode="AU" term="%22Assaf+S%22">Assaf S</searchLink>; Cumming School of Medicine, University of Calgary, Calgary, Alberta.; Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, Alberta.<br /><searchLink fieldCode="AU" term="%22Hao+X%22">Hao X</searchLink>; Cumming School of Medicine, University of Calgary, Calgary, Alberta.; Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, Alberta.<br /><searchLink fieldCode="AU" term="%22Snelling+S%22">Snelling S</searchLink>; Cumming School of Medicine, University of Calgary, Calgary, Alberta.; Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, Alberta.<br /><searchLink fieldCode="AU" term="%22Meode+M%22">Meode M</searchLink>; Cumming School of Medicine, University of Calgary, Calgary, Alberta.; Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, Alberta.<br /><searchLink fieldCode="AU" term="%22Hassam+R%22">Hassam R</searchLink>; Cumming School of Medicine, University of Calgary, Calgary, Alberta.; Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, Alberta.<br /><searchLink fieldCode="AU" term="%22Cseh+O%22">Cseh O</searchLink>; Cumming School of Medicine, University of Calgary, Calgary, Alberta.<br /><searchLink fieldCode="AU" term="%22Kala+S%22">Kala S</searchLink>; Standard BioTools, Canada Inc, Markham, Ontario.<br /><searchLink fieldCode="AU" term="%22Pemberton+J%22">Pemberton J</searchLink>; Standard BioTools, Canada Inc, Markham, Ontario.<br /><searchLink fieldCode="AU" term="%22Chan+JA%22">Chan JA</searchLink>; Cumming School of Medicine, University of Calgary, Calgary, Alberta.; Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, Alberta.<br /><searchLink fieldCode="AU" term="%22Cairncross+JG%22">Cairncross JG</searchLink>; Cumming School of Medicine, University of Calgary, Calgary, Alberta.; Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, Alberta.<br /><searchLink fieldCode="AU" term="%22Forsyth+P%22">Forsyth P</searchLink>; Mofitt Cancer Center and Research Institute, Tampa, Florida (P.F.).<br /><searchLink fieldCode="AU" term="%22Yong+VW%22">Yong VW</searchLink>; Cumming School of Medicine, University of Calgary, Calgary, Alberta.<br /><searchLink fieldCode="AU" term="%22Mirzaei+R%22">Mirzaei R</searchLink>; Department of Oncology, University of Alberta, Edmonton, Alberta.; Cross Cancer Institute, University of Alberta, Edmonton, Alberta.<br /><searchLink fieldCode="AU" term="%22Weiss+S%22">Weiss S</searchLink>; Cumming School of Medicine, University of Calgary, Calgary, Alberta.; Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, Alberta.<br /><searchLink fieldCode="AU" term="%22Zemp+FJ%22">Zemp FJ</searchLink>; Cumming School of Medicine, University of Calgary, Calgary, Alberta.; Department of Biochemistry and Molecular Biology, University of Calgary, Calgary, Alberta.<br /><searchLink fieldCode="AU" term="%22Luchman+HA%22">Luchman HA</searchLink>; Cumming School of Medicine, University of Calgary, Calgary, Alberta.; Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, Alberta.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101755003%22">Neuro-oncology advances</searchLink> [Neurooncol Adv] 2025 Oct 15; Vol. 8 (1), pp. vdaf226. <i>Date of Electronic Publication: </i>2025 Oct 15 (<i>Print Publication: </i>2026).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101755003 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2632-2498 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2226322498%22">26322498 </searchLink><i>NLM ISO Abbreviation: </i>Neurooncol Adv <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41568176
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1093/noajnl/vdaf226
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: vdaf226
    Titles:
      – TitleFull: IGF2 supports glioblastoma growth and immune evasion through a combination of tumor cell-intrinsic and -extrinsic mechanisms.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Heemskerk KM
      – PersonEntity:
          Name:
            NameFull: Assaf S
      – PersonEntity:
          Name:
            NameFull: Hao X
      – PersonEntity:
          Name:
            NameFull: Snelling S
      – PersonEntity:
          Name:
            NameFull: Meode M
      – PersonEntity:
          Name:
            NameFull: Hassam R
      – PersonEntity:
          Name:
            NameFull: Cseh O
      – PersonEntity:
          Name:
            NameFull: Kala S
      – PersonEntity:
          Name:
            NameFull: Pemberton J
      – PersonEntity:
          Name:
            NameFull: Chan JA
      – PersonEntity:
          Name:
            NameFull: Cairncross JG
      – PersonEntity:
          Name:
            NameFull: Forsyth P
      – PersonEntity:
          Name:
            NameFull: Yong VW
      – PersonEntity:
          Name:
            NameFull: Mirzaei R
      – PersonEntity:
          Name:
            NameFull: Weiss S
      – PersonEntity:
          Name:
            NameFull: Zemp FJ
      – PersonEntity:
          Name:
            NameFull: Luchman HA
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 15
              M: 10
              Text: 2025 Oct 15
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 2632-2498
          Numbering:
            – Type: volume
              Value: 8
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Neuro-oncology advances
              Type: main
ResultId 1